Skip to main content
. 2021 Nov 23;12:788321. doi: 10.3389/fendo.2021.788321

Figure 1.

Figure 1

COVID-19 can cause erectile dysfunction. The potential mechanism of how COVID-19 infection is related to erectile dysfunction through impairing endothelial cell and smooth muscle cell (top panel); Ang1-7 is a potential novel drug target to treat erectile dysfunction in COVID-19 patients (bottom panel). ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; ED, erectile dysfunction; ROS, reactive oxygen species; AMPK, AMP-activated protein kinase; Ang1-7, angiotensin 1-7; Ang II, angiotensin 2; PDE, phosphodiesterase; 5’GMP, Guanosine-5’-monophosphate; cGMP, cyclic guanosine monophosphate; PKG, Cyclic GMP–dependent protein kinase; NOS, nitric oxide synthase. This scheme was created using BioRender, accessed on Sept. 29, 2021.